HUMAN NEURAL STEM CELLS DIFFERENTIATED INTO NEURONS
Disease Areas
BrainCells is focusing its initial efforts on the treatment of mood disorders and believes its technology has applications in other CNS-related markets such as cognition and neurodegeneration.
Expanding Relevance of Neurogenesis
Since its discovery in 1998, scientists have continued to add to an ever-growing list of areas where neurogenesis may be relevant, including:
- Mood disorders
- Cognition
- Memory
- Neuro-degeneration
- Stress
Market Opportunity and BrainCells Development Programs
Brain related illness afflicts more than 1.5 billion people worldwide. According to NeuroInsights, companies selling neuropharmaceutical products generated in excess of $100 billion in global revenues in 2008 and represent the top selling category of drugs in the world. BrainCells is developing novel therapeutics based on our proprietary neurogenesis platform to address this large market opportunity by advancing a number of programs into the clinic, including two in Phase 2 trials.